Cypre Inc. is a biotechnology company.
Cypre is dedicated to overcoming therapeutic resistance for cancer patients. They are applying the platform with therapeutic innovators for drug discovery and combination screening across various modalities.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 15, 2018 | Convertable Note | — | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
The Next Impact | — | Convertable Note |
Novit Ventures | — | Convertable Note |